What Companies Can Do To Address Prescription Drug Market Manipulation [Forbes]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Forbes
managers (PBM) that threatens to upend a productive balance between rewarding manufacturer innovation and lowering patient costs. Recently, some PBMs have used their leverage to block biosimilars or favor more expensive ones produced by their parent companies. The trend is costing patients and businesses, stifling innovation and taxing our economy. From 2021 to 2025, biosimilar savings were under expectation according to the American Journal of Managed Care . One need not look further than the well-publicized games that drug middlemen play to understand why. PROMOTED In , Peter Kolchinsky, biotechnology thought leader, advocates for a system where drugs enjoy a period of patent protection to incentivize research and devel
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIOPR Newswire
- For Colon Cancer That No Longer Responds to Treatment, A New Drug Combination Offers Hope [Yahoo! Finance]Yahoo! Finance
- Is Amgen Inc. (AMGN) a Cheap NASDAQ Stock to Buy According to Hedge Funds? [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ: AMGN) is now covered by analysts at Cantor Fitzgerald. They set a "neutral" rating and a $305.00 price target on the stock.MarketBeat
- Amgen (AMGN) Stock Moves -1.3%: What You Should Know [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 2/4/25 - Beat
AMGN
Sec Filings
- 4/17/25 - Form DEFA14A
- 4/17/25 - Form SCHEDULE
- 4/16/25 - Form PX14A6G
- AMGN's page on the SEC website